Initial clinical data for BDC-4182 Phase 1 dose escalation study expected in 3Q 2026 Cash balance of $38.8 million as of September 30, 2025 anticipated to fund key milestones into 2027 REDWOOD CITY, ...
Mutations drive evolution, but they can also be risky. New research led by plant biologists at the University of California, ...
Boosting levels of a certain molecule that declines with age was found to restore memory and brain function in Alzheimer’s ...
NMNAT2 is a key protein required for axon integrity whose rapid depletion following axon injury triggers Wallerian ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback